Full member
Sumit Arora
  • 37, Male
  • Mobile, AL
  • United States
Share on Facebook
Share

Sumit Arora's Friends

  • Sasipriya
  • Bala Naidu
  • Dr. Arindam Adhikari
  • Margit Malatschnig
  • Dr. Prashant Kumar
  • Kristen Kulinowski
  • seda
  • Sanjay
  • Steffen B. Petersen
  • seda koksal

Sumit Arora's Groups

 

Sumit Arora's Page

Latest Activity


Full member
Sumit Arora updated their profile
Jun 27

Full member
Sumit Arora and Sasipriya are now friends
Oct 23, 2009

Full member
Sumit Arora left a comment for Jitender kumar
"Dear Jitender, Thanks a lot"
Oct 22, 2009

Full member
Jitender kumar left a comment for Sumit Arora
"HI Sumit Happy Birthday to you from Jitender Kumar"
Oct 22, 2009

Full member
Sumit Arora left a comment for Joan
"Hello Joan, nice to know that you are also working in the same area, I am working as an Asst. professor, Do write to me whenever required any help in this work"
Sep 26, 2009

Full member
Steffen B. Petersen left a comment for Sumit Arora
"We are working specifically with the reactivity of disulphide bridges in proteins - and we have verified that we can open them with UV light, provided that they are flanked with an aromatic group, eg TRP. In the open reactive state they can react…"
Sep 26, 2009

Full member
Sumit Arora updated their profile photo
Sep 26, 2009

Full member
Sumit Arora replied to CH.L.R.Jaidev's discussion Antimicrobial activity of silver nanoparticles.
"1.Strong interaction with thiol groups present in cell respiratory enzymes in the microbe cell. 2.Interaction with structural proteins and preferential binding with DNA bases to inhibit replication. 3.Binding of the silver ion to free sulphydryl…"
Sep 26, 2009

Profile Information

I am...
Biologist, Doctor
My research field or area of interest innanotechnology
Nanomedicine, Pancreatic Cancer, Skin Cancer
Interest in...
Anti-cancer and chemo-preventive activity of natural compounds,Identification and characterization of novel therapeutic targets against cancer,Development of novel nano-delivery system to target cancer cells,Nanotoxicology, silver nanoparticles
Publication list
1. Arora, S., Tyagi, N., Deshmukh S. K., Singh, S., Marimuthu, S., Singh, A.P. (2015). Mission possible: Exploiting nanoways for the development of microRNA-based cancer therapeutics. Journal of Biomedical Nanotechnology (Accepted for publication)

2. Arora, S., Tyagi, N., Bhardwaj, A., Rusu, L., Palanki, R., Vig, K., Singh S.R., Singh A.P., Palanki, S., Miller, M. E., Carter J.E., Singh, S. (2015). Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis. Nanomedicine: Nanotechnology, biology and Medicine. 11:1265–1275.

3. Arora, S., Swaminathan, S.K., Kirtane, A., Srivastava, S.K., Bhardwaj, A., Singh, S., Panyam, J., Singh, A.P. (2014). Synthesis, characterization, and evaluation of poly (D, L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. International Journal of Nanomedicine. 9:2933-42.

4. Arora, S., Bhardwaj, A., Singh, S., Srivastava, S.K., McClellan S., Nirodi C.S., Piazza, G.A., Grizzle W.E., Owen, L, B., Singh, A.P., (2013). An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated upregulation of CXCR4. Journal of Biological chemistry. 288(29):21197-207.

5. Arora, S., Singh, S., Piazza, G.A., Contreas, C.M., Panyam, J., and Singh, A.P. (2012). Honokiol: a novel natural agent for cancer prevention and therapy. Current Molecular Medicine. 12 (10); 1244-1252.

6. Arora, S., Rajwade, J.M., Paknikar, K.M., (2012). Nanotoxicology and in vitro studies: the need of the hour. Toxicology and applied pharmacology. 258:151-165.

7. Arora, S., Bhardwaj, A., Srivastava, S., Singh, S., McClellan, S., Wang, B & Singh, A.P. (2011). Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS ONE. 6 (6): e21573.

8. Arora, S., Jain, J.,Rajwade, J.M., Paknikar, K.M., (2009). Interactions of silver nanoparticles with primary mouse fibroblast and liver cells. Toxicology and applied pharmacology, 236, 310-318.

9. Arora, S., Jain, J., Rajwade J.M., Paknikar K.M., (2008). Cellular responses induced by silver nanoparticles: in vitro studies. Toxicology Letters, 179, 93-100.

10. Khan M.A., Srivastava S.K., Bhardwaj A., Singh S., Arora S., Zubair H., Carter J.E., Singh A.P. (2015). Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications. Oncotarget. (Accepted for publication)

11. Srivastava S.K, Bhardwaj A., Arora S., Tyagi N., Singh A.P., Carter J.E, Scammell J.G, Fodstad Ø, Singh S. (2015). Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis. British journal of cancer. 112(11):1772-1781.

12. Srivastava, S.K., Arora, S., Averett, C., Singh, S., Singh, A.P. (2015). Modulation of MicroRNAs by Phytochemicals in Cancer: Underlying Mechanisms and Translational Significance. BioMed Research International. 2015,1-9.

13. Bhardwaj, A., Srivastava, S.K., Singh, S., Arora, S., Tyagi, N., Andrews, J., McClellan, S., Carter, J.E., Singh, A.P. (2014). CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1. Oncotarget. 5 (22):11490-500.

14. Bhardwaj, A., Singh, S., Srivastava S.K., Arora, S., Hyde, S.J., Andrews, J., Grizzle, W.E., Singh A.P. (2014). Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model. British journal of cancer. 110 (8), 2000-2010.

15. Srivastava, S.K., Arora, S., Singh, S., Bhardwaj, A., Averett, C., Singh, A.P. (2014). MicroRNAs in Pancreatic Malignancy: Progress and Promises. Cancer Letters. S0304-3835(14)00106-2.

16. Bhardwaj, A., Arora, S., Prajapati, V.K., Singh, S., and Singh, A.P. (2013). Cancer stemness-regulating miRNAs: role, mechanisms and therapeutic potential. Current Drug Targets.14 (10):1175-84.

17. Singh, A.P., Arora,S., Bhardwaj, A., Srivastava, S.K., Kadakia, M.P., Wang, B., Grizzle W.E., Owen, L,B., Singh, S (2012). CXCL12/CXCR4 signaling axis induces SHH expression in pancreatic cancer cells via ERK- and Akt- mediated activation of NF-κB: implications for bidirectional tumor-stromal interactions. Journal of Biological chemistry. 287(46):39115-24.


18. Srivastava S.K., Bhardwaj A., Singh S., Arora S., McClellan S., Grizzle W.E., Reed E., and Singh A.P. (2012). Myb overexpression overrides androgen depletion- induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration-resistance. Carcinogenesis. 33(6):1149-1157.

19. Malhi S.S., Budhiraja A., Arora S., Chaudhari K.R., Nepali K., Kumar R., Sohi H., and Murthy R.S. (2012). Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes. International Journal of Pharmaceutics. 432(1-2):63-74.

20. Srivastava S., Bhardwaj A., Singh S., Arora S., Wang B., Grizzle W.E., and Singh A.P. (2011). MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis. 32(12):1832-1839.

21. Jain, J., Arora, S., Rajwade J.M., Omray, P., Khandelwal, S., Paknikar K.M., (2009). Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use. Molecular Pharmaceutics, 6 (5), 1388–1401.

22. Kale, S.N., Rajagopal, R., Arora, S., Bhayani, K.R., Rajwade, J.M., Paknikar K.M., kundaliya, D.C., Ogale, S.B., (2007) Microwave response of La0.7Sr0.3MnO3 nanoparticles for heating applications. Journal of Biomedical Nanotechnology. 3, 178-183.

23. Bhayani, K.R., Kale, S.N., Arora, S., Rajagopal, R., Mamgain, H., Kaul-Ghanekar, R., Kundaliya, D.C., Kulkarni, S.D., pasricha, R., Dhole, S.D., Ogale, S.B., Paknikar, K.M., (2007). Protein and polymer immobilized La0.7Sr0.3MnO3 nanoparticles for possible biomedical applications. Nanotechnology.18, 1-7.

24. Kale, S.N., Arora, S., Bhayani, K.R., Paknikar, K.M., Rajagopal, R., Jani, M., Wagh, U.V., Kulkarni, S.D., Ogale, S.B., (2006). Cerium doping and stoichiometry control for biomedical use of La0.7Sr0.3MnO3 nanoparticles: microwave absorption and cytotoxicity study. Nanomedicine: Nanotechnology, biology and Medicine. 2, 217-221.
Researchgroup, Institute, University, School, Company name
USAMCI, Mobile NIPER, Mohali, ISF Moga, ARI Pune
Researchgroup, Institute, Company, University, School webpage
http://www.usahealthsystem.com/our_teams
The network creator will send periodical messages to members - you below to allow us to email you
yes

Comment Wall (4 comments)

You need to be a member of The International NanoScience Community to add comments!

Join The International NanoScience Community

At 7:59am on October 22, 2009,
Full member
Jitender kumar
said…
HI Sumit Happy Birthday to you from Jitender Kumar
At 9:32am on September 26, 2009,
Full member
Steffen B. Petersen
said…
We are working specifically with the reactivity of disulphide bridges in proteins - and we have verified that we can open them with UV light, provided that they are flanked with an aromatic group, eg TRP. In the open reactive state they can react with gold surfaces, or gold nano particles.
As of yet we have not tried Silver, or Aluminum, but we expect Silver to be working well.

It could be interesting to mount antimicrobial peptides onto Silver nanoparticles, and check if their antimicrobial efficiency goes up or not

If you are interested in knowing mor please check our WEB pages for more info :

http://www.nanobio.dk and select eg publications

Regards

Steffen B. Petersen
At 6:29am on May 28, 2009,
Full member
Bala Naidu
said…
Hi Sumit
At 1:56pm on October 15, 2008,
Full member
Joan
said…
Hi.Sumit... We are doing the same science... I am still in first grade of my graduate school.... keep in touch!
 
 
 

Next partner events of TINC

We are Media Partner of:

Welcome - about us

Welcome! Nanopaprika was cooked up by Hungarian chemistry PhD student in 2007. The main idea was to create something more personal than the other nano networks already on the Internet. Community is open to everyone from post-doctorial researchers and professors to students everywhere.

There is only one important assumption: you have to be interested in nano!

Nanopaprika is always looking for new partners, if you have any idea, contact me at editor@nanopaprika.eu

Dr. András Paszternák, founder of Nanopaprika

Publications by A. Paszternák:

The potential use of cellophane test strips for the quick determination of food colours

pH and CO2 Sensing by Curcumin-Coloured Cellophane Test Strip

Polymeric Honeycombs Decorated by Nickel Nanoparticles

Directed Deposition of Nickel Nanoparticles Using Self-Assembled Organic Template,

Organometallic deposition of ultrasmooth nanoscale Ni film,

Zigzag-shaped nickel nanowires via organometallic template-free route

Surface analytical characterization of passive iron surface modified by alkyl-phosphonic acid layers

Atomic Force Microscopy Studies of Alkyl-Phosphonate SAMs on Mica

Amorphous iron formation due to low energy heavy ion implantation in evaporated 57Fe thin films

Surface modification of passive iron by alkylphosphonic acid layers

Formation and structure of alkylphosphonic acid layers on passive iron

Structure of the nonionic surfactant triethoxy monooctylether C8E3 adsorbed at the free water surface, as seen from surface tension measurements and Monte Carlo simulations